ArticleChinese medicine2019

Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation.

Zhu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.